But analysts see this as an encouraging shift of stance on part of Indian pharma companies that have so far been dependent on the patents challenge route.
Religare, a Ranbaxy group company providing financial services, has joined hands with Dutch insurer Aegon to set up life insurance and asset management venture in the country.
No one would have dreamt then that, in the space of a generation, Delhi would be challenging Mumbai to become the country's business capital.
Former US President Bill Clinton's foundation has reached an agreement with eight pharmaceutical companies worldwide, including India's Cipla and Ranbaxy, to drastically lower the prices of AIDS tests and drugs.
The gap between stand-alone Indian figures and global figures can be the difference between sell and buy.
Fortis Healthcare, promoted by the Singh family of Ranbaxy, plans to expand its network to 40 hospitals within three years by either acquiring new facilities or setting up greenfield projects
Ranbaxy group company Fortis Healthcare has said its acquisition of Escorts Heart Institute and Research Centre from Rajan Nanda's Escorts did not require "prior consent of Delhi Development Authority".
Slated to become the second healthcare company after Apollo Hospitals to go public, Fortis will offload up to 25 per cent equity through the IPO. The rest will remain with the promoter family.
Having moved into original research, they have attracted overseas professionals looking to come back, some nudged by MNCs' narrowing research.
There is a cluster of three buildings in Gurgaon that one can easily lose in the landscape of this Delhi suburb. But once inside, you cannot miss the smell of white powder or the rustle of some 1,400 lab coats.
Unhappy with Chinese machinery and raw materials they have been importing so far, Pakistani pharmaceutical companies are now longing to increase their business ties with India, and asked New Delhi to relax the "stringent visa norms".
The US continues to be the most important part of our overseas portfolio
Transcript of the market chat held on January 17.
The markets opened very strong today on the back of positive global cues
The Tata group has earmarked about Rs 1,000 crore (Rs 10 billion) for investment over the next four years in Advinus Therapeutics, a joint venture floated by it and ex-Ranbaxy research head Rashmi Barbhaiya.
A nervous energy that keeps you going, a passion to do something different, and the grit to tide over any crisis are the ingredients, say panelists at the TiE Summit.
Fortis Healthcare Limited, part of Ranbaxy Group, has announced plans to increase the number of its hospitals from 10 to 25 in the next 3 to 4 years, with a vision to set up a world class super speciality network.
NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family members in their presence.
Anil has requested the ministry to take appropriate action in the matter in the interest of the public.
The markets opened strong on F&O expiry today despite some mixed global cues
The markets opened firm on Tuesday and crossed the 7,800 mark after opening with a gain of 7 points at 7,774.
"My family reputation kept me a silent spectator, as I mutely watched the organisation I founded come to a point where it was publicly auctioned; where my family and myself have been stripped of our legacy, our finances and my personal credibility."
Markets closed the day in green on favourable domestic factors,
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances